Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study.


Journal

Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 13 09 2022
accepted: 14 03 2023
revised: 06 02 2023
medline: 29 8 2023
pubmed: 26 3 2023
entrez: 25 3 2023
Statut: ppublish

Résumé

Vitiligo patients may desire laser hair removal, skin rejuvenation, vascular treatments, and other laser or intense pulsed light (IPL) assisted treatments. However, there is a risk of inducing new depigmented patches (Koebner phenomenon). In absence of guidelines on the safe use of laser or IPL in vitiligo patients, dermatologists tend to be reluctant to administer these treatments. The aim of this survey study was to provide an estimation of the occurrence and related risk factors of laser/IPL-induced leukoderma or vitiligo. A cross-sectional survey study was performed among 15 vitiligo experts from 11 countries, with 14 questions about affected patients, involved laser/IPL treatments and the physicians' approach. In a total of 11,300 vitiligo patients, laser/IPL-induced leukoderma or vitiligo was reported in 30 patients (0.27%). Of these, 12 (40%) patients had a medical history of vitiligo and seven (58%) of these patients had stable (> 12 months) vitiligo before the treatment. Most frequently reported were hair removal procedures and localization of the face and legs. Side effects like blistering, crusting, and erosions occurred in 56.7% of the cases. These vitiligo experts based their advice on the risk of the laser treatment on stability of the vitiligo (43%) and activity signs (50%), and 50% discuss the risks before starting a laser treatment. Relevant activity signs are the Koebner phenomenon (57.1%), confetti-like lesions (57.1%) and hypochromic borders (50%). Laser-induced leukoderma or vitiligo is an uncommon phenomenon. Remarkably, a minority had a medical history of vitiligo of which 58% were stable. Consequently, most cases could not have been prevented by not treating vitiligo patients. However, a majority had laser/IPL-induced skin damage. Therefore, caution is advised with aggressive settings and test-spots prior to the treatment are recommended. This study showed significant variation in the current recommendations and approach of vitiligo experts regarding laser/IPL-induced leukoderma or vitiligo.

Identifiants

pubmed: 36964767
doi: 10.1007/s00403-023-02611-8
pii: 10.1007/s00403-023-02611-8
pmc: PMC10462531
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2289-2294

Informations de copyright

© 2023. The Author(s).

Références

Ezzedine K, Eleftheriadou V, Whitton M, van Geel N (2015) Vitiligo Lancet 386(9988):74–84
doi: 10.1016/S0140-6736(14)60763-7 pubmed: 25596811
Thissen M, Westerhof W (1997) Laser treatment for further depigmentation in vitiligo. Int J Dermatol 36(5):386–388
doi: 10.1046/j.1365-4362.1997.00144.x pubmed: 9199992
Van Geel N, Speeckaert R, De Wolf J et al (2012) Clinical significance of Koebner phenomenon in vitiligo. Br J Dermatol 167(5):1017–1024
doi: 10.1111/j.1365-2133.2012.11111.x pubmed: 22950415
Van Geel N, Speeckaert R, Taieb A et al (2011) Koebner’s phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res 24(3):564–573
doi: 10.1111/j.1755-148X.2011.00838.x pubmed: 21324101
van Geel N, Grine L, De Wispelaere P et al (2019) Clinical visible signs of disease activity in vitiligo: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 33(9):1667–1675
doi: 10.1111/jdv.15604 pubmed: 31131483
Post NF, Van Broekhoven NX, Bekkenk MW, Wolkerstorfer A (2022) Laser- and intense pulsed light (IPL)-induced vitiligo patches: a systematic review of the literature - short report. Lasers Med Sci.
Sharma A, Minh Duc N et al (2021) A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med 36:3179–3187
doi: 10.1007/s11606-021-06737-1 pubmed: 33886027 pmcid: 8481359
Gan SD, Graber EM (2013) Laser hair removal: a review. Dermatol Surg 39(6):823–838
doi: 10.1111/dsu.12116 pubmed: 23332016
Lim SPR, Lanigan SW (2006) A review of the adverse effects of laser hair removal. Lasers Med Sci 21:121–125
doi: 10.1007/s10103-006-0377-y pubmed: 16816888
Kim YJ, Chung BS, Choi KC (2001) Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis. Dermatol Surg 27:969–970
pubmed: 11737134
Van Geel N, Depaepe L, Speeckaert R (2015) Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study. J Eur Acad Dermatol Venereol 29(6):1121–1127
doi: 10.1111/jdv.12762 pubmed: 25286980
Van Geel N, Passeron T, Wolkerstorfer A et al (2020) Reliability and validity of the Vitiligo Signs of Activity Score (VSAS). Br J Dermatol 183(5):883–890
doi: 10.1111/bjd.18950 pubmed: 32064583 pmcid: 7687072

Auteurs

Nicoline F Post (NF)

Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. n.f.post@amsterdamumc.nl.

Noah X Van Broekhoven (NX)

Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Annelies Lommerts (A)

Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Jung M Bae (JM)

Department of Dermatology, St. Vincent's Hospital, Seoul, South Korea.

Marcel W Bekkenk (MW)

Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Caio C Silva de Castro (CCS)

Department of Dermatology, Pontifical Catholic University of Paraná, Curitiba, Brazil.

Viktioria Eleftheriadou (V)

Department of Dermatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.

Samia Esmat (S)

Department of Dermatology, Cairo University, Giza, Egypt.

Khaled Ezzedine (K)

Department of Dermatology, Université Paris-Est Créteil Val de Marne-Université Paris, Paris, France.

Nanja van Geel (N)

Department of Dermatology, Ghent University Hospital, Ghent, Belgium.

Iltefat Hamzavi (I)

Department of Dermatology, Henry Ford Health System, Detroit, MI, USA.

Giovanni Leone (G)

Dermatology Department, Israelite Hospital, Rome, Italy.

Amit G Pandya (AG)

Department of Dermatology, Palo Alto Foundation Medical Group, Sunnyvale, CA, USA.

Thierry Passeron (T)

Department of Dermatology and INSERM U1065, University Hospital of Nice, Nice, France.

Michelle A Rodrigues (MA)

Chroma Dermatology, Pigment and Skin of Colour Centre, Victoria, Australia.

Julien Seneschal (J)

Department of Dermatology and Pediatric Dermatology, University Hospital, Bordeaux, France.

Steven Th'ng (S)

Department of Dermatology, Skin Research Institute of Singapore, Singapore, Singapore.

Albert Wolkerstorfer (A)

Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH